Publications

   
Date Title 1st author Journal

01/04/2012

 

Genes with a spike expression are clustered in chromosome (sub)bands and spike (sub)bands have a powerful   prognostic value in patients with multiple myeloma

 

 Kassambara A Haematologica
31/07/2012

 

Identification of Pluripotent   and Adult Stem Cell Genes Unrelated to Cell Cycle and Associated with Poor   Prognosis in Multiple Myeloma

 

 Kassambara A PLoS One
01/08/2012 Antiangiogenic Therapeutic   Approaches in Multiple Myeloma  Ribatti D Current Cancer Drug Targets
18/10/2012 Development of gene expression   based score to predict sensitivity of multiple myeloma cells to DNA   methylation inhibitors  Moreaux J Molecular Cancer Therapeutics
27/10/2012 Dll1/Notch activation   contributes to bortezomib resistance  by upregulating CYP1A1 in multiple   myeloma.  Xu D Biochemical and Biophysical   Research Communications
03/11/2012

 

Residual malignant and normal   plasma cells shortly after high dose melphalan and stem cell transplantation.   Highlight of a putative therapeutic window in Multiple Myeloma?

 

 Caraux A Oncotarget
01/12/2012 STEAP1 is overexpressed in   cancers: A promising therapeutic target  Moreaux J Biochemical and Biophysical   Research Communications
01/01/2013

 

Pentraxin 3 (PTX3) inhibits   plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma   patients.

 

 Basile A.

Journal of Pathology
30/01/2013

 

Multiple myeloma macrophages:   pivotal players in the tumor microenvironment

 

 Berardi S Journal of Oncology
01/03/2013

 

The role of angiogenesis in   human non-Hodgkin lymphomas

 

 Ribatti D

Neoplasia
01/04/2013

 

Exome sequencing in tracking   clonal evolution in multiple myeloma following therapy.

 

 Weston-Bell N Leukemia
12/04/2013

 

Kruppel-like factor 4 blocks   tumor cell proliferation and promotes drug resistance in multiple myeloma.

 

 Schoenhals M Haematologica
19/04/2013

 

Tumor cells in multiple myeloma   patients inhibit myeloma-reactive T cells through carcinoembryonic   antigen-related cell adhesion molecule-6

 

 Witzens-Harig   MNeben K Blood
30/04/2013

 

Inhibition of DEPDC1A, a bad   prognostic marker in multiple myeloma, delays growth and induces mature   plasma cell markers in malignant plasma cells

 

 Kassambara A PLoS One
01/05/2013

 

Heparan sulfate proteoglycans in   the control of B cell development and the pathogenesis of multiple myeloma

 

 Reijmers, R M FEBS Journal
26/06/2013

 

Novel targeting of phospho-cMET   overcomes drug resistance and induces anti-tumor activity in multiple   myeloma

 

 Moschetta M Clinical Cancer Research
01/08/2013

 

The hypoxia target   adrenomedullin is aberrantly expressed in multiple myeloma and promotes   angiogenesis

 

 Kocemba K A Leukemia
21/08/2013 MHC Class I Antigen Processing   and Presenting Machinery: Organization, Function, and Defects in Tumor Cells  Leone P Journal of the National Cancer   Institute
01/09/2013 DNA repair pathways in human   multiple myeloma  Gourzones-   Dmitriev C Cell Cycle
01/10/2013

 

Erythropoietin is involved in   the angiogenic potential of bone marrow macrophages in multiple myeloma

 

 De Luisi A Angiogenesis
01/12/2013

 

Progression in Smoldering   Myeloma Is Independently Determined by the Chromosomal Abnormalities   del(17p), t(4;14), Gain 1q, Hyperdiploidy, and Tumor Load

 

 Neben K Journal of Clinical Oncology
26/12/2013 The Glycome of Normal and   Malignant Plasma Cells  Moehler T M PLoS One
01/01/2014

 

Bone marrow vascular niche and  the control of angiogenesis in multiple myeloma

 

 Ribatti D Frontiers in Bioscience
01/02/2014

 

DNA methylation score is   predictive of myeloma cell sensitivity to 5-azacitidine

 

 Moreaux J British Journal of Haematology
15/02/2014

 

HIF-1  of Bone Marrow   Endothelial Cells Implies Relapse and Drug Resistance in Patients with   Multiple Myeloma and May Act as a Therapeutic Target

 

 Ria R Clinical Cancer Research

01/04/2014

 

Bone marrow fibroblasts parallel   multiple myeloma progression in patients and mice: in vitro and in vivo   studies

 

 Frassanito   Dammacco M A Leukemia
01/05/2014 Microenvironment and multiple   myeloma spread  Ribatti D Thrombosis Research
15/05/2014

 

A DNA repair pathway score   predicts survival in human multiple myeloma: the potential for therapeutic  strategy

 

 Kassambara A Oncotarget
01/08/2014

 

IL-6 supports the generation of   human long-lived plasma cells in combination with either APRIL or stromal   cell-soluble factors

 

 Jourdan M Leukemia
01/08/2014 Role of endothelial progenitor   cells in cancer progression  Moschetta M Biochimica et Biophysica Acta -   Reviews on Cancer
01/08/2014

 

Therapeutic targeting of the  mTOR-signalling pathway in cancer: benefits and limitations

 

 Moschetta M British Journal of Pharmacology
01/09/2014

 

Cancer Associated Fibroblasts   and Tumor Growth: Focus on Multiple Myeloma

 

 Veirman K Cancers
26/09/2014

 

Preclinical efficacy of   sepantronium bromide (YM155) in multiple myeloma is conferred by down   regulation of Mcl-1

 

 Wagner V Oncotarget
01/10/2014 Macrophages in multiple myeloma  Ribatti D Immunology Letters
15/11/2014

 

A HGF/cMET Autocrine Loop Is   Operative in Multiple Myeloma Bone Marrow Endothelial Cells and May Represent  a Novel Therapeutic Target

 

 Ferrucci A Clinical Cancer Research
01/12/2014

 

Stimulation of invariant natural   killer T cells by α-Galactosylceramide activates the JAK-STAT pathway in   endothelial cells and reduces angiogenesis in the 5T33 multiple myeloma model

 

 Haneen N British Journal of Haematology
08/12/2014 Myeloid-Derived Suppressor Cells as Therapeutic Target in Hematological Malignancies  Veirman K Frontiers in Oncology
01/01/2015 Identify multiple myeloma stem   cells: Utopia?  Saltarella, I World Journal of Stem Cells
29/01/2015

 

GenomicScape: An Easy-to-Use Web   Tool for Gene Expression Data Analysis. Application to Investigate the   Molecular Events in the Differentiation of B Cells into Plasma Cells

 

 Kassambara, A PLoS Computational Biology
01/02/2015

 

Cellular uptake kinetics of   bortezomib in relation to efficacy in myeloma cells and the influence of drug   transporters

 

 Clemens, C Cancer Chemotherapy &   Pharmacology
20/02/2015

 

In vivo treatment with   epigenetic modulating agents induces transcriptional alterations associated   with prognosis and immunomodulation in multiple myeloma

 

 Maes K Oncotarget
20/02/2015 Cancer associated fibroblasts in   hematological malignancies  Raffaghello L Oncotarget
01/03/2015

 

The 7p15.3 (rs4487645)   association for multiple myeloma shows strong allele-specific regulation of   the MYC-interacting gene CDCA7L in malignant plasma cells

 

 Weinhold N Haematologica
20/03/2015

 

Drug metabolism and clearance   system in tumor cells of patients with multiple myeloma

 

 Hassen W Oncotarget
01/04/2015

 

Association of Antigen-Specific   T-cell Responses with Antigen Expression and Immunoparalysis in Multiple   Myeloma

 

 Fichtner S Clinical Cancer Research
30/04/2015

 

Multiple myeloma induces Mcl-1   expression and survival of myeloid-derived suppressor cells

 

 De Veirman K Oncotarget
30/05/2015

 

Massive parallel IGHV gene   sequencing reveals a germinal center pathway in origins of human multiple   myeloma.

 

 Cowan G Oncotarget
01/07/2015

 

Myeloma cells act as tolerogenic   antigen-presenting cells and induce regulatory T cells in vitro

 

 

 Frassanito MA European Journal of Haematology
Overmyr © 2012